Quantitative Determination of Flexible Pharmacological Mechanisms Based On Topological Variation in Mice Anti-Ischemic Modular Networks

Targeting modules or signalings may open a new path to understanding the complex pharmacological mechanisms of reversing disease processes. However, determining how to quantify the structural alteration of these signalings or modules in pharmacological networks poses a great challenge towards realizing rational drug use in clinical medicine. Here, we explore a novel approach for dynamic comparative and quantitative analysis of the topological structural variation of modules in molecular networks, proposing the concept of allosteric modules (AMs). Based on the ischemic brain of mice, we optimize module distribution in different compound-dependent modular networks by using the minimum entropy criterion and then calculate the variation in similarity values of AMs under various conditions using a novel method of SimiNEF. The diverse pharmacological dynamic stereo-scrolls of AMs with functional gradient alteration, which consist of five types of AMs, may robustly deconstruct modular networks under the same ischemic conditions. The concept of AMs can not only integrate the responsive mechanisms of different compounds based on topological cascading variation but also obtain valuable structural information about disease and pharmacological networks beyond pathway analysis. We thereby provide a new systemic quantitative strategy for rationally determining pharmacological mechanisms of altered modular networks based on topological variation.

[1]  Chuan-Yun Li,et al.  KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases , 2011, Nucleic Acids Res..

[2]  Z. Luthey-Schulten,et al.  Dynamical networks in tRNA:protein complexes , 2009, Proceedings of the National Academy of Sciences.

[3]  Jacques van Helden,et al.  Evaluation of clustering algorithms for protein-protein interaction networks , 2006, BMC Bioinformatics.

[4]  Ruth Nussinov,et al.  Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.

[5]  E. Horjales,et al.  The allosteric transition of glucosamine-6-phosphate deaminase: the structure of the T state at 2.3 A resolution. , 1999, Structure.

[6]  M. Moskowitz,et al.  Reduced Brain Edema and Infarction Volume in Mice Lacking the Neuronal Isoform of Nitric Oxide Synthase after Transient MCA Occlusion , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  R. Guimerà,et al.  Functional cartography of complex metabolic networks , 2005, Nature.

[8]  Jason A. Papin,et al.  Metabolic pathways in the post-genome era. , 2003, Trends in biochemical sciences.

[9]  Wu Jun Network Structure Entropy and Its Application to Scale-free Networks , 2004 .

[10]  L. Pitts,et al.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. , 1986, Stroke.

[11]  Zhong Wang,et al.  Modular pharmacology: the next paradigm in drug discovery , 2012, Expert opinion on drug discovery.

[12]  Livia Perfetto,et al.  MINT, the molecular interaction database: 2012 update , 2011, Nucleic Acids Res..

[13]  A. Barabasi,et al.  Network medicine : a network-based approach to human disease , 2010 .

[14]  R. Nussinov,et al.  Allosteric conformational barcodes direct signaling in the cell. , 2013, Structure.

[15]  J. Changeux,et al.  Allosteric Mechanisms of Signal Transduction , 2005, Science.

[16]  R. Nussinov,et al.  Allostery in Disease and in Drug Discovery , 2013, Cell.

[17]  K. Sneppen,et al.  Specificity and Stability in Topology of Protein Networks , 2002, Science.

[18]  Zhong Wang,et al.  Modular pharmacology: deciphering the interacting structural organization of the targeted networks. , 2013, Drug discovery today.

[19]  Peter Csermely,et al.  Heat Shock Partially Dissociates the Overlapping Modules of the Yeast Protein-Protein Interaction Network: A Systems Level Model of Adaptation , 2011, PLoS Comput. Biol..

[20]  Delbert Dueck,et al.  Clustering by Passing Messages Between Data Points , 2007, Science.

[21]  C Y Hsu,et al.  Expression of c‐fos and c‐jun family genes after focal cerebral ischemia , 1993, Annals of neurology.

[22]  Dirk M. Lorenz,et al.  The emergence of modularity in biological systems. , 2011, Physics of life reviews.

[23]  M Zimmermann,et al.  Rapid and long-lasting suppression of the ATF-2 transcription factor is a common response to neuronal injury. , 1998, Brain research. Molecular brain research.

[24]  Zhang Zhan-jun Differences in pharmacological pathways among Qingkailing effective component , 2010 .

[25]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[26]  Zaida Luthey-Schulten,et al.  Exploring residue component contributions to dynamical network models of allostery. , 2012, Journal of chemical theory and computation.

[27]  Jun Liu,et al.  Outcome-dependent global similarity analysis of imbalanced core signaling pathways in ischemic mouse hippocampus. , 2012, CNS & neurological disorders drug targets.

[28]  E. Andrianantoandro,et al.  Synthetic biology: new engineering rules for an emerging discipline , 2006, Molecular systems biology.

[29]  Ruth Nussinov,et al.  The spatial structure of cell signaling systems , 2013, Physical biology.

[30]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[31]  R. Tsien,et al.  Specificity and Stability in Topology of Protein Networks , 2022 .

[32]  T. Dinan,et al.  Exciting Times beyond the Brain: Metabotropic Glutamate Receptors in Peripheral and Non-Neural Tissues , 2011, Pharmacological Reviews.

[33]  Guodong Li,et al.  Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration , 2015, Acta pharmaceutica Sinica. B.

[34]  D M DUNLOP,et al.  The Antihistamine Drugs , 1949, The Journal of pharmacy and pharmacology.

[35]  Rafael C. Jimenez,et al.  The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..

[36]  Lazaros G. Papageorgiou,et al.  Module detection in complex networks using integer optimisation , 2010, Algorithms for Molecular Biology.

[37]  H Watanabe,et al.  Cerebral ischemia model with conscious mice. Involvement of NMDA receptor activation and derangement of learning and memory ability. , 1990, Journal of pharmacological methods.

[38]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[39]  Yanan Yu,et al.  Variations in target gene expression and pathway profiles in the mouse hippocampus following treatment with different effective compounds for ischemia–reperfusion injury , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

[40]  Kristin Blacklock,et al.  Differential Modulation of Functional Dynamics and Allosteric Interactions in the Hsp90-Cochaperone Complexes with p23 and Aha1: A Computational Study , 2013, PloS one.

[41]  Wang Jian-xin Research on robustness of PPI networks based on normalized entropy , 2009 .

[42]  Yanan Yu,et al.  Decoding the Polyphyletic Flexibility of Allosteric Modular Networks: Progress and Perspectives. , 2016, Critical reviews in eukaryotic gene expression.

[43]  R. Nussinov,et al.  Allo-network drugs: harnessing allostery in cellular networks. , 2011, Trends in pharmacological sciences.

[44]  R. Nussinov,et al.  Send Orders of Reprints at Reprints@benthamscience.net Allo-network Drugs: Extension of the Allosteric Drug Concept to Protein- Protein Interaction and Signaling Networks , 2022 .

[45]  Jennifer M. Rust,et al.  The BioGRID Interaction Database , 2011 .

[46]  Jun Liu,et al.  Fusion of core pathways reveals a horizontal synergistic mechanism underlying combination therapy. , 2011, European journal of pharmacology.

[47]  Anton J. Enright,et al.  An efficient algorithm for large-scale detection of protein families. , 2002, Nucleic acids research.

[48]  Csaba Böde,et al.  Perturbation waves in proteins and protein networks: applications of percolation and game theories in signaling and drug design. , 2008, Current protein & peptide science.

[49]  A. Hoffmann,et al.  Circuitry of nuclear factor kappaB signaling. , 2006, Immunological reviews.

[50]  S. Dudoit,et al.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.

[51]  S. Thiagalingam,et al.  A cascade of modules of a network defines cancer progression. , 2006, Cancer research.

[52]  C. Langmead,et al.  Quantitative Analysis Reveals Multiple Mechanisms of Allosteric Modulation of the mGlu5 Receptor in Rat Astroglia , 2011, Molecular Pharmacology.

[53]  R. Sharan,et al.  Network-based prediction of protein function , 2007, Molecular systems biology.

[54]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[55]  Bruce Tidor,et al.  MIST: Maximum Information Spanning Trees for dimension reduction of biological data sets , 2009, Bioinform..

[56]  Himori Norio,et al.  Cerebral ischemia model with conscious mice. Involvement of NMDA receptor activation and derangement of learning and memory ability. , 1990 .

[57]  Marcus Kaiser,et al.  Criticality of spreading dynamics in hierarchical cluster networks without inhibition , 2007, 0802.2508.

[58]  Sailu Yellaboina,et al.  Prediction of evolutionarily conserved interologs in Mus musculus , 2008, BMC Genomics.

[59]  Susumu Goto,et al.  Network analysis identifies a putative role for the PPAR and type 1 interferon pathways in glucocorticoid actions in asthmatics , 2012, BMC Medical Genomics.

[60]  Kara Dolinski,et al.  The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..